Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID | UniProt ID ▲ | Title | Descriptor |
|---|---|---|---|
| 6VZZ | 6VZZ | Crystal structure of glucokinase from Balamuthia mandrillaris in complex with glucose | |
| 6W03 | 6W03 | Crystal Structure of HIV-1 BG505 DS-SOSIP.3mut Prefusion Env Trimer in Complex with Human Antibodies 3H109L and 35O22 at 3.3 Angstrom | |
| 6W16 | 6W16 | Crystal structure of a human metapneumovirus monomeric fusion protein complexed with 458 Fab | |
| 6W2B | 6W2B | Anomalous bromine signal reveals the position of Br-paroxetine complexed with the serotonin transporter at the central site | |
| 6W3H | 6W3H | Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeys | |
| 6W41 | 6W41 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with human antibody CR3022 | |
| 6W4M | 6W4M | CRYSTAL STRUCTURE OF THE ADCC-POTENT, WEAKLY NEUTRALIZING HIV ENV CO-RECEPTOR BINDING SITE ANTIBODY N12-I2 FAB IN COMPLEX WITH HIV-1 CLADE A/E GP120 AND M48U1 | |
| 6W5Y | 6W5Y | Inferred receptor binding domain of human endogenous retrovirus envelope EnvP(b)1 | EnvP(b)1 inferred receptor binding domain |
| 6W9G | 6W9G | Crystal Structure of the Fab fragment of humanized 5c8 antibody containing the fluorescent non-canonical amino acid L-(7-hydroxycoumarin-4-yl)ethylglycine in complex with CD40L at pH 6.8 | |
| 6WAQ | 6WAQ | Crystal structure of the SARS-CoV-1 RBD bound by the cross-reactive single-domain antibody SARS VHH-72 | |
| 6WAR | 6WAR | Crystal structure of the MERS-CoV RBD bound by the neutralizing single-domain antibody MERS VHH-55 | |
| 6WAS | 6WAS | Structure of D19.PA8 Fab in complex with 1FD6 16055 V1V2 scaffold | |
| 6WB4 | 6WB4 | Microbiome-derived Acarbose Kinase Mak1 Labeled with selenomethionine | |
| 6WB5 | 6WB5 | Microbiome-derived Acarbose Kinase Mak1 as a Complex with Acarbose and AMP-PNP | |
| 6WBT | 6WBT | 2.52 Angstrom Resolution Crystal Structure of 6-phospho-alpha-glucosidase from Gut Microorganisms in Complex with NAD and Glucose-6-phosphate | |
| 6WEQ | 6WEQ | DENV1 NS1 in complex with neutralizing 2B7 Fab fragment | |
| 6WER | 6WER | DENV2 NS1 in complex with neutralizing 2B7 Fab fragment | |
| 6WEX | 6WEX | Crystal Structure of Broadly Neutralizing Antibody 3I14-D93N Mutant Bound to the Influenza A H6 Hemagglutinin | |
| 6WEZ | 6WEZ | Crystal Structure of Broadly Neutralizing Antibody 3I14-D93N Mutant Bound to the Influenza A H3 Hemagglutinin | |
| 6WF0 | 6WF0 | Crystal Structure of Broadly Neutralizing Antibody 3I14 Bound to the Influenza A H3 Hemagglutinin | |
| 6WF1 | 6WF1 | Crystal Structure of Broadly Neutralizing Antibody 3I14 Bound to the Influenza A H10 Hemagglutinin | |
| 6WGL | 6WGL | Dupilumab fab with Crystal Kappa design complexed with human IL-4 receptor | |
| 6WHK | 6WHK | Minimally mutated anti-influenza broadly neutralizing antibody | |
| 6WHW | 6WHW | GluN1b-GluN2B NMDA receptor in complex with GluN2B antagonist SDZ 220-040, class 1 | Ionotropic glutamate receptor , NMDA receptor GluN1b, Ionotropic glutamate receptor , NMDA receptor GluN2B |
| 6WHX | 6WHX | GluN1b-GluN2B NMDA receptor in complex with GluN2B antagonist SDZ 220-040, class 2 | Ionotropic glutamate receptor , NMDA receptor GluN1b, Ionotropic glutamate receptor , NMDA receptor GluN2B |
| 6WHY | 6WHY | GluN1b-GluN2B NMDA receptor in complex with GluN1 antagonist L689,560, class 1 | Ionotropic glutamate receptor , NMDA receptor GluN1b, Ionotropic glutamate receptor , NMDA receptor GluN2B |
| 6WI1 | 6WI1 | GluN1b-GluN2B NMDA receptor in active conformation stabilized by inter-GluN1b-GluN2B subunit cross-linking | Ionotropic glutamate receptor , NMDA receptor GluN1b, Ionotropic glutamate receptor , NMDA receptor GluN2B |
| 6WIT | 6WIT | Crystal structure of NHP D15.SD7 Fab in complex with 16055 V1V2 1FD6 scaffold | |
| 6WIX | 6WIX | Crystal Structure of HIV-1 MI369 RnS-DS.SOSIP Prefusion Env Trimer in Complex with Human Antibodies 3H109L and 35O22 at 3.5 Angstrom | |
| 6WIZ | 6WIZ | Crystal structure of Fab 54-1G05 bound to H1 influenza hemagglutinin | |
| 6WJ1 | 6WJ1 | Crystal structure of Fab 54-4H03 bound to H1 influenza hemagglutinin | |
| 6WK8 | 6WK8 | Crystal structure of Gdx-Clo from Small Multidrug Resistance family of transporters in complex with phenylguanidinium | |
| 6WK9 | 6WK9 | Crystal structure of Gdx-Clo from Small Multidrug Resistance family of transporters in complex with octylguanidinium | |
| 6WO3 | 6WO3 | Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody U1 | |
| 6WO4 | 6WO4 | Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody HC11 | |
| 6WO5 | 6WO5 | Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 1a bound to neutralizing antibody 212.1.1 and non neutralizing antibody E1 | |
| 6WOQ | 6WOQ | Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 1a bound to neutralizing antibody HC1AM and non neutralizing antibody E1 | |
| 6WP8 | 6WP8 | Proton-pumping mutant of Mastigocladopsis repens rhodopsin chloride pump | |
| 6WPS | 6WPS | Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment | SARS-CoV-2 spike glycoprotein, S309 neutralizing antibody heavy chain, S309 neutralizing antibody light chain |
| 6WPS | 6WPS | Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment | SARS-CoV-2 spike glycoprotein, S309 neutralizing antibody heavy chain, S309 neutralizing antibody light chain |
| 6WPT | 6WPT | Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment (open state) | SARS-CoV-2 spike glycoprotein, S309 neutralizing antibody heavy chain, S309 neutralizing antibody light chain |
| 6WPT | 6WPT | Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment (open state) | SARS-CoV-2 spike glycoprotein, S309 neutralizing antibody heavy chain, S309 neutralizing antibody light chain |
| 6WRV | 6WRV | Crystal structure of computationally designed protein 3DS18 in complex with the human Transferrin receptor ectodomain | |
| 6WRW | 6WRW | Crystal structure of computationally designed protein 2DS25.5 in complex with the human Transferrin receptor ectodomain | |
| 6WRX | 6WRX | Crystal structure of computationally designed protein 2DS25.1 in complex with the human Transferrin receptor ectodomain | |
| 6WTH | 6WTH | Full-length human ENaC ECD | Amiloride-sensitive sodium channel subunit alpha, Amiloride-sensitive sodium channel subunit beta, Amiloride-sensitive sodium channel subunit gamma, 7B1 Fab, 10D4 Fab |
| 6WVZ | 6WVZ | Crystal structure of anti-MET Fab arm of amivantamab in complex with human MET | |
| 6WW7 | 6WW7 | Structure of the human ER membrane protein complex in a lipid nanodisc | ER membrane protein complex subunit 1, ER membrane protein complex subunit 2, ER membrane protein complex subunit 3, ER Membrane Protein Complex Subunit 4, Membrane magnesium transporter 1, ER membrane protein complex subunit 6, ER membrane protein complex subunit 7, ER membrane protein complex subunit 8, ER membrane protein complex subunit 10 |
| 6WXL | 6WXL | Cryo-EM structure of the VRC315 clinical trial, vaccine-elicited, human antibody 1D12 in complex with an H7 SH13 HA trimer | |
| 6WYR | 6WYR | Crystal structure of anti-Muscle Specific Kinase (MuSK) Fab, MuSK1A |
